Active	Status	Sponsor type	Region	Phase	Filter
15 Active 21 Inactive 36 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

15 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ashina, Messoud
REFORM, NCT04603976: Registry for Migraine - Clinical Core	Recruiting	4	1000	Europe	Erenumab, Aimovig	Danish Headache Center	Migraine	10/22	10/22
ATOM, NCT05211154: Evaluation of the Efficacy of Diclofenac Potassium and Rimegepant for the Acute Treatment of Migraine	Recruiting	4	645	Europe	Diclofenac Potassium 50Mg/Pkt Oral Pwdr, Voltfast, Rimegepant 75 MG	Danish Headache Center	Migraine With Aura, Migraine Without Aura	12/24	12/25
ATOM, NCT05214001: Evaluation of the Efficacy of Almotriptan and Ubrogepant for the Acute Treatment of Migraine	Recruiting	4	645	Europe	Almotriptan 12.5 Mg Oral Tablet, Almogran, Ubrogepant 50Mg Tab, Ubrelvy	Messoud Ashina, MD	Migraine With Aura, Migraine Without Aura	12/24	12/25
REFORM, NCT04674020: Registry for Migraine - Structural and Functional MRI Before and After Erenumab Treatment	Recruiting	4	250	Europe	Erenumab, Aimovig	Danish Headache Center	Migraine, Headache	07/25	07/25
NCT04592952: Hypersensitivity to CGRP as a Predictive Biomarker of Migraine Prevention With Erenumab	Recruiting	4	400	Europe	Calcitonin Gene-Related Peptide, CGRP, Erenumab, Aimovig	Danish Headache Center	Migraine	08/25	08/25
NCT04452929: The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients	Recruiting	N/A	72	Europe	Erenumab, Aimovig®, Placebo, Saline placebo, Calcitonin gene-related peptide, Cilostazol	Danish Headache Center, Novartis Pharmaceuticals	Migraine, Migraine Without Aura, Migraine With Aura	02/22	07/22
NCT05093582: The Effects of Levcromakalim in Patients With Cluster Headache	Completed	N/A	41	Europe	Levcromakalim, Saline, Isotonic saline, 0.9% saline	Danish Headache Center	Cluster Headache	09/22	09/22
ILMO, NCT04853797: Effect of Ivabradine on Levcromakalim-Induced Symptoms in Individuals With Migraine Without Aura (ILIM)	Recruiting	N/A	30	Europe	Levcromakalim, Ivabradine, Placebo	Danish Headache Center	Headache, Migraine Without Aura	01/25	01/25
NCT04744129: Headache Inducing Effect of NN414 in Migraine Patients	Recruiting	N/A	16	Europe	NN414, 6-Chloro-3-[[1-methylcyclopropyl]amino]-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide, Saline	Danish Headache Center	Headache, Migraine	02/23	02/23
NCT04905654: Migraine Inducing Effect of Levcromakalim in Patients With Migraine With Aura	Completed	N/A	35	Europe	Levcromakalim, Saline	Danish Headache Center	Headache, Migraine, Aura	05/23	05/23
COLLIDE, NCT05889442: Effect of Levcromakalim in Individuals With Migraine Pretreated With Erenumab	Completed	N/A	16	Europe	Levcromakalim, Placebo	Danish Headache Center, Novartis	Migraine Without Aura	06/23	06/23
COMPETE, NCT05889455: Effect of Sildenafil in Individuals With Migraine Pretreated With Erenumab	Completed	N/A	16	Europe	Sildenafil, Placebo	Danish Headache Center, Novartis	Migraine Without Aura	10/23	10/23
NCT05582811: Effect of Riocigaut on Cerebral Vasodilation and Headache Induction in Healthy Volunteers	Completed	N/A	15	Europe	Dose Riociguat 2,5 or 5mg, Riociguat, Placebo	Danish Headache Center	Headache	06/23	06/23
NCT05750446: Effect of Riocigaut on Migraine Attack Induction in People With Migraine	Completed	N/A	22	Europe	Riociguat (BAY 63-2521), Adempas, Placebo	Danish Headache Center	Migraine Without Aura	02/24	02/24
SLIM, NCT05211050: Effect of Sumatriptan on Levcromakalim-Induced Symptoms in Individuals With Migraine	Recruiting	N/A	20	Europe	Levcromakalim, Sumatriptan, Saline	Danish Headache Center	Migraine Without Aura, Headache	01/25	01/25
Christensen, Casper E
No trials found